CaliPharms Profit Margin

CaliPharms (KGET) currently reports a profit margin of -5677.83% as of September 2014. That is below the Industrials sector average of 10.37%. Use the charts on this page to explore CaliPharms's profit margin history and peer comparisons.

CaliPharms's profit margin of -5677.83% is lower than the Industrials sector average of 10.37%. That is roughly 54850.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but CaliPharms's current -5677.83% should be judged against Industrials norms (sector average: 10.37%) and against KGET's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -5677.83%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 10.37%. From there, open related valuation or income-statement pages for CaliPharms, and consider following KGET for alerts when major investors trade the stock.

CaliPharms is classified in the Industrials sector. On profit margin, it currently shows -5677.83% versus a sector average near 10.37%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing KGET with unrelated industries.